Melbourne, Jan 15, 2008 AEST (ABN Newswire) - Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) wishes to advise of its progress in licensing its core intellectual property pertaining to non-coding DNA.
During the 2007 financial year, GTG earned $11.3 million in license fees which was significantly higher than in previous years. So far this financial year, the Company has continued to make good progress with approximately $6.6 million in license fees having been received to the end of December 2007.
Several new licenses, including those previously announced, as well as licenses recently granted to Kimball Genetics and Prometheus Laboratories have helped GTG to generate a solid first half result. While predicting the timing and quantum of future license fees is inherently difficult, the Company remains satisfied with the progress of its licensing program.
Contact
Michael B. Ohanessian
Chief Executive Officer
Phone: +61 3 8412 7000
| ||
|
